
Joint Pain Injections Market by Injection Type (Corticosteroid Injections, Hyaluronic Acid Injections), Joint Type (Facet Joints of the Spine, Hip Joint, Knee & Ankle), Distribution Channel - Global Forecast 2024-2030
Description
Joint Pain Injections Market by Injection Type (Corticosteroid Injections, Hyaluronic Acid Injections), Joint Type (Facet Joints of the Spine, Hip Joint, Knee & Ankle), Distribution Channel - Global Forecast 2024-2030
The Joint Pain Injections Market size was estimated at USD 4.55 billion in 2023 and expected to reach USD 5.04 billion in 2024, at a CAGR 10.94% to reach USD 9.42 billion by 2030.
Global Joint Pain Injections Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Joint Pain Injections Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Joint Pain Injections Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Joint Pain Injections Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., Asterisk Laboratories (I) Pvt. Ltd., Bioventus LLC, Chugai Pharmaceutical Co., Ltd., Ferring B.V., Henry Schein, Inc., Hetero Healthcare Limited, Krosyl Pharmaceuticals Pvt. Ltd., Medilink Pharma, Pfizer Inc., Salavidas Pharmaceutical Pvt. Ltd., Sanofi S.A., Seikagaku Corporation, TEENA LABS LTD, Wellona Pharma, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
This research report categorizes the Joint Pain Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:
Injection Type
Corticosteroid Injections
Hyaluronic Acid Injections
Joint Type
Facet Joints of the Spine
Hip Joint
Knee & Ankle
Shoulder & Elbow
Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Joint Pain Injections Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Joint Pain Injections Market?
3. What are the technology trends and regulatory frameworks in the Joint Pain Injections Market?
4. What is the market share of the leading vendors in the Joint Pain Injections Market?
5. Which modes and strategic moves are suitable for entering the Joint Pain Injections Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Joint Pain Injections Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of joint disorders across globe
- 5.1.1.2. Rising cases of rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma
- 5.1.1.3. Availability of awareness programs by government organizations
- 5.1.2. Restraints
- 5.1.2.1. High cost of the joint pain injections
- 5.1.3. Opportunities
- 5.1.3.1. Advancement in osteoarthritis pain treatment
- 5.1.3.2. Growing awareness about benefits of intra-articular injections
- 5.1.4. Challenges
- 5.1.4.1. Lack of awareness regarding injections
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Joint Pain Injections Market, by Injection Type
- 6.1. Introduction
- 6.2. Corticosteroid Injections
- 6.3. Hyaluronic Acid Injections
- 7. Joint Pain Injections Market, by Joint Type
- 7.1. Introduction
- 7.2. Facet Joints of the Spine
- 7.3. Hip Joint
- 7.4. Knee & Ankle
- 7.5. Shoulder & Elbow
- 8. Joint Pain Injections Market, by Distribution Channel
- 8.1. Introduction
- 8.2. Hospital Pharmacies
- 8.3. Online Pharmacies
- 8.4. Retail Pharmacies
- 9. Americas Joint Pain Injections Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Joint Pain Injections Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.
- 10. South Korea
- 10.
- 11. Taiwan
- 10.
- 12. Thailand
- 10.
- 13. Vietnam
- 11. Europe, Middle East & Africa Joint Pain Injections Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.
- 10. Nigeria
- 11.
- 11. Norway
- 11.
- 12. Poland
- 11.
- 13. Qatar
- 11.
- 14. Russia
- 11.
- 15. Saudi Arabia
- 11.
- 16. South Africa
- 11.
- 17. Spain
- 11.
- 18. Sweden
- 11.
- 19. Switzerland
- 11.
- 20. Turkey
- 11.
- 21. United Arab Emirates
- 11.
- 22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Anika Therapeutics, Inc.
- 13.1.2. Asterisk Laboratories (I) Pvt. Ltd.
- 13.1.3. Bioventus LLC
- 13.1.4. Chugai Pharmaceutical Co., Ltd.
- 13.1.5. Ferring B.V.
- 13.1.6. Henry Schein, Inc.
- 13.1.7. Hetero Healthcare Limited
- 13.1.8. Krosyl Pharmaceuticals Pvt. Ltd.
- 13.1.9. Medilink Pharma
- 13.1.
- 10. Pfizer Inc.
- 13.1.
- 11. Salavidas Pharmaceutical Pvt. Ltd.
- 13.1.
- 12. Sanofi S.A.
- 13.1.
- 13. Seikagaku Corporation
- 13.1.
- 14. TEENA LABS LTD
- 13.1.
- 15. Wellona Pharma
- 13.1.
- 16. Zimmer Biomet Holdings, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. JOINT PAIN INJECTIONS MARKET RESEARCH PROCESS
- FIGURE 2. JOINT PAIN INJECTIONS MARKET SIZE, 2023 VS 2030
- FIGURE 3. JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. JOINT PAIN INJECTIONS MARKET DYNAMICS
- FIGURE 7. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2030 (%)
- FIGURE 8. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2030 (%)
- FIGURE 10. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 12. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.